1
Total investments
0
Early stage
0
Mid stage
1
Late stage
2y
Years active
Portfolio
1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2024
Portfolia is the most powerful community of women and men investing in the companies we want in the world.
Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity.
Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity.
We drive change while creating wealth.
If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
Experience Β· 2 entries
All (2)
Investments (1)
2024
Investor
Jul 2024
Portfolia is the most powerful community of women and men investing in the companies we want in the world.
Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity.
Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity.
We drive change while creating wealth.
If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.
2013
Associate Director of Marketing
Jun 2013
Ion Torrent has developed a DNA sequencing system that directly translates chemical signals (A, C, G, T) into digital information (0, 1) on a semiconductor chip. The result is a sequencing system that is simpler, faster, more cost effective and scalable than any other technology available. Because Ion Torrent produces its proprietary semiconductor chips in standard CMOS factories, we leverage the $1 trillion dollar investment that has been made in the semiconductor industry over the past 40 years. This enables us to directly benefit from four decades of exponential improvement in semiconductor technology, usually expressed as Mooreβs Law.
The company was founded in August 2007 by Jonathan Rothberg, a pioneer of high-speed, massively parallel DNA sequencing. Ion Torrent is based in Guilford, Connecticut with offices in San Francisco. Ion Torrent will launch the Ion Personal Genome Machine sequencer in 2010. For more information about Ion Torrent, visit www.lifetechnologies.com/iontorrent
